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z Organic & Supramolecular Chemistry
Syntheses of Combretastatin A-4 and Related Stilbenes by
Using Aqueous Conditions
Natalie G. Barnes,[a, b] Amjed A. Ahmed Mal Ullah,[a, c] Patricia A. Ragazzon,[a, d] Nadia Charafi,[a]
and John A. Hadfield*[a]
Combretastatin A-4 (CA4) is a potent anti-mitotic and vascular
disrupting agent. Organic chemists have been working to
optimize the synthesis of CA4 for the past 3 decades, with
methods requiring hazardous solvents and harsh reaction
conditions. Here, we report the synthesis of CA4 and a variety
of stilbenes in an aqueous Wittig system.
Potassium carbonate or lithium hydroxide were used as base in
this Wittig reaction to give excellent yields of mixtures of E-
and Z-stilbenes. The synthesis of CA4 was achieved using
tetrahydropyran (THP) or silyl protected phenolic aldehydes.
The THP groups were removed using dilute acid whilst the silyl
groups fortuitously fell off during work up.
Introduction
Until recent years, chemists have synthesised target molecules
without realising the environmental impacts of the solvents
and reagents required in these synthetic procedures.[1] In
general, synthetic procedures can produce a huge amount of
chemical and solvent waste. Green chemistry has a far and
wide effect in both the chemical and pharmaceutical industry.
Both synthetic and medicinal chemists are in a continuous
search to find an eco-friendly route in the area of drug
development.
There are a number of advances for the environmentally
friendly synthesis of biologically active molecules such as
microwave assisted synthesis,[2,3] solid phase synthesis,[4]
ultrasound,[5] catalyst-free and one-pot syntheses.[6] Organic
synthesis in water has attracted the attention of chemists for
many years. Water is one of the most inexpensive and
environmentally benign solvents.
Combretastatin A-4 (CA4, 1 a, Figure 1), a natural product
isolated from the South African tree Combretum caffrum,
exhibits potent anti-mitotic effects as well as being a lead
vascular disrupting agent. CA4 binds to the colchicine site of
tubulin, disrupting microtubule polymerisation and eventually
inducing apoptosis. In its water-soluble disodium phosphate
derivative form (CA4P, 1 b, Figure 1), it has undergone several
clinical trials as an antimour agent on its own, or in
combination with other cytotoxic agents.[7] Owing to its
antivascular properties CA4P has also been trialled to combat
age-related macular degeneration.[8] A poly(L-glutamic acid)
nanoparticle conjugate of combretastatin A-4, used for im-
proved delivery, has shown the ability to suppress C26 colon
carcinoma tumours in mice by 74% whilst CA4P’s tumour
suppression rate was considerably lower (24%).[9] In combina-
tion with tirapazamine this conjugate caused complete tumour
reduction in 4T1 xenograft mice.[10]
There have been various routes described for the synthesis
of CA4 (1 a). The original synthesis described by Pettit et al.
dates back to 1995 and uses Wittig chemistry (Scheme 1).[11]
Here flammable solvents and reagents (tetrahydrofuran/n-
butyllithium) are used to form the silyl protected E- and Z-
stilbenes (3 a, 3 b, Figure 1) as a mixture and the reaction
requires an inert atmosphere to exclude moisture and oxygen.
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Figure 1. Structure of Z- and E-combretastatin A-4 (1), combretastatin A-4
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Separation using silica chromatography followed by desilyla-
tion provides the E- and Z-isomers of CA4 (1 a, 1 b). This Wittig
method is not stereoselective and so substantially reduces the
yield potential of the biologically active Z-isomer.
More recently, methods which produce solely the Z-isomer
of CA4 (1 a) have been described.[12] One method uses a Suzuki
coupling starting from isovanillin (6) (Scheme 2). Although this
method produces solely Z-CA4 (1 a) it requires protection and
deprotection of the phenol to allow a good yield of the
intermediate dibromo olefin (9) and the use of a toxic tin
reagent and carbon tetrabromide to provide the Z-vinyl
bromide (10). Coupling this bromide (10) with 3,4,5-trimeth-
oxyphenyl boronic acid (11) yields Z-CA4 (1 a).
This selective Suzuki coupling has recently been improved
to yield Z-CA4 (1 a) in an overall yield of 56%.[13] In this method,
the Z-vinyl iodide (14) was readily prepared using Stork-Zhao
olefination methodology[14] from phosphonium iodide (13) and
3,4,5-trimethoxybenzaldehyde (12) in the presence of Sodium
bis(trimethylsilyl)amide (NaHMDS, scheme 3). Suzuki-coupling
of this Z-iodostyrene (14) compound with 3-hydroxy-4-meth-
oxyphenyl boronic acid (15) produced solely Z-CA-4 (1 a) in
78% yield, avoiding the need for protection and deprotection
steps, and more importantly avoiding the use of highly toxic
carbon tetrabromide and tin.
Another method that produces solely the Z-isomer is the
Perkin condensation reaction reported by Gaukroger et al. in
2001. The Perkin-type condensation of 3,4,5-trimethoxyphenyl
Scheme 1. Original synthesis of combretastatin A-4.[11] Reagents and conditions: a) n-Butyl Lithium, THF, Ar,   20 °C, 56% (3 a), 37% (3 b); b) t-butylammonium
fluoride, THF, 39% (1 a), 39% (1 b).
Scheme 2. Suzuki cross coupling synthesis of Z-CA-4.[12] Reagents and conditions: a) t-Butyldimethylsilyl chloride (TBDMSCl), DMF, Ar, 2 h, 67% (7); b); carbon
tetrabromide, triphenylphosphine, DCM, 0 °C, 20 min, 62% (8); c) tetra-n-butylammonium fluoride (TBAF), THF, Ar, 20 min, 88% (9); d) t-butyltin hydride,
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acetic acid (16) with isovanillin (6) yields the cinnamic acid (17)
in good yield. Decarboxylation then yields Z-CA4 (1 a) in 70%
yield (Scheme 4). However, this decarboxylation step requires
strong heating and the use of toxic quinoline.[12]
Although the later syntheses of CA4 have improved
substantially; both in yield and the safety of materials used
since the first synthesis was reported in 1995, these methods
still require the use of somewhat hazardous solvents and harsh
reaction conditions.[15] There are other methods described in
the literature for carrying out the Wittig reaction in water alone
(scheme 5) and using a base (scheme 6). El-Batta and co-
workers reported that heating (methoxycarbonylmethylene)
triphenylphosphorane (18) with o-anisaldehyde (19) at room
temperature for 1 hour afforded the ester (20) as a mixture of
E- and Z- alkenes in 81% yield with an E/Z ratio of 76/24. No
base was required for this Wittig reaction in water.[16]
The E-pterostilbene (23) in scheme 6 has been prepared by
reacting tosylated phosphonium salt (21) with aldehyde (22) in
Scheme 3. Improved Suzuki cross coupling synthesis of Z-CA-4.[13] Reagents and conditions: a) NaHMDS, THF,   20 to   78 °C, 2 h, 72% (14); b) tetrakis
(triphenylphosphine)palladium(0), sodium carbonate (Na2CO3, 2 M), DME, 80 °C, 20 h, 78% (1 a).
Scheme 4. Perkin reaction.[12] Reagents and conditions: a) triethylamine, acetic anhydride, reflux, 60% (17); b: Cu, quinoline, 200 °C, 72% (1 a).
Scheme 5. Example Wittig reaction in water.[16] Reagents and conditions: a) water, 20 °C, 81% (20) E/Z ratio of 76/24.




7084ChemistrySelect 2021, 6, 7082–7086 © 2021 The Authors. ChemistrySelect published by Wiley-VCH GmbH
Wiley VCH Montag, 26.07.2021
2128 / 213726 [S. 7084/7086] 1
water using lithium hydroxide as base for this Wittig reaction.
Acid hydrolysis afforded stilbene (23) predominantly as the E-
isomer (<5% Z) (Scheme 6).[17]
Results and Discussion
With the above aqueous reactions, and their indvidual
difficulties in mind, it was prudent to develop a fresh approach
for the synthesis of combretastatin A-4 (1 a) and related
stilbenes. For these Wittig reactions both lithium hydroxide and
potassium carbonate were used as a base. Potassium carbonate
has been previously used in Wittig-Horner reactions with
aliphatic aldehydes to generate E-alkenes.[15] The phosphonium
bromide (4) was heated with a range of aldehydes (Scheme 7)
in the presence of three equiv. lithium hydroxide or three
equiv. potassium carbonate in one millilitre of water. In all
cases, except when isovanillin (6) was used to try to prepare
combretastatin A-4 (1 a, 1 b), a mixture of E- and Z-stilbenes
was isolated. Also, no stilbene was formed when using 3-
hydroxybenzaldehyde or 4-hydroxybenzaldehyde under these
aqueous Wittig methodologies. With the failure of this method-
ology to yield stilbenes from phenolic substrates, alternative
methods were sought to generate combretastatin A-4 (1 a)
using aqueous conditions. The tetrahydropyranyl ethers of
combretastatin A-4 (24 l, 25 l) have already been described in
the literature and were synthesised from phosphonium salt (4)
and THP protected isovanillin using a solid phase column
containing alumina-KF and tetrahydrofuran. Using our aqueous
methodology these two stilbenes (24 l, 25 l) were synthesised
in excellent yields using both LiOH (69%) and K2CO3 (82%) in
water, as shown in Table 1. Separation followed by treatment
with dilute HCl to cleave off the protecting groups yielded Z-
and E-combretastatin A-4 (1 a, 1 b) quantitatively. The silyl
ethers of both combretastatin A-4 (3 a, 3 b) have also already
Scheme 7. Aqueous synthesis of combretastatin library. Reagents and conditions: a) LiOH or K2CO3 (3 equiv), water, reflux, 16 h.
Table 1. Yield of Z- and E- stilbenes using LiOH or K2CO3 as base in a water Wittig reaction.
LiOH K2CO3
Aldehyde Z E Total Z E Total
24,25 a 4-Chloro 26.90% 23.60% 50.50% 33.70% 27.00% 60.70%
24,25 b 4-Fluoro 26.10% 36.50% 62.60% 22.70% 35.40% 58.10%
24,25 c 2-NO2 38.80% 38% 76.80% 25.70% 25.50% 51.20%
24,25 d 3-NO2 29.40% 36.50% 65.90% 32.40% 24.60% 57.00%
24,25 e 4-NO2 28.38% 33.40% 61.78% 26.80% 22.80% 49.60%
24,25 f 4-Methoxy 17.90% 28.40% 46.30% 24.60% 13.30% 37.90%
24,25 g 3,4,5-Trimethoxy 30.70% 25.30% 56.00% 25.20% 20.60% 45.80%
24,25 h 3-Fluoro-4-methoxy 27.50% 31.20% 58.70% 34.20% 30.00% 64.20%
24,25 i Benzaldehyde 35.80% 23.80% 59.60% 29.40% 25.20% 54.60%
24,25 j 4-Trifluoromethyl 31.60% 26.30% 57.90% 30.60% 21.50% 52.10%
24,25 k 4-Cyano 32% 37% 69.00% 27.20% 24.90% 52.10%
24,25 l[a] 3-Tetrahydropyranoxy-4-methoxybenzaldehyde 32% 37% 69% 37% 45% 82%
3a,3b[a] 3-[(t-Butyldimethylsilyl)oxy]-4-methoxybenzaldehyde 31% 42% 73% 41% 48% 89%
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been described in the literature.[11] These were synthesised
using our LiOH and K2CO3 protocols in water. After work up,
the silyl ethers (3 a, 3 b) were not isolated and solely Z- and E-
combretastatin A-4 (1 a, 1 b) were produced in excellent yields
(LiOH, 73%) (K2CO3, 89%, Table 1).
Conclusion
The methodology described herein has shown that the Wittig
reaction using both potassium carbonate and lithium
hydroxide in water can be used to synthesise the antivascular
agent combretastatin A- 4 (1 a) in good yield. The synthetic
method does not work when the benzaldehydes in the reaction
possess a phenolic group. Therefore, THP and silyl protected
phenols were used in the Wittig reaction to generate the
required phenolic stilbenes (1 a, 1 b). The THP protected
stilbenes were readily cleaved with dilute HCl whilst the silyl
groups fortuitously fell off during work up to provide Z- and E-
combretastatin A-4. This methodology was also successful for
preparing a variety of other trimethoxyphenyl substituted
stilbenes.
Supporting Information Summary
Full experimental details and NMR spectra for this article are
available in the supporting information.
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